On September 19th the Venture Challenge Fall 2022 will commence!

Bart Steensma, Postdoctoral Researcher at University Medical Center Utrecht, is selected to particitate in The Venture Challenge with PrecorDx, reducing heart failure hospitalizations with wearable diagnostics. He will be joined by Nico van den Berg, professor and head of the Computational Imaging group , and Jaap de Bruin, Fundmanager at Utrecht Health Seed Fund.

We look forward to the next steps!


During an intense 10 weeks, the 5 selected teams will develop a solid business case to bring their scientific invention to market and benefit researchers, doctors and patients.

The teams entering this edition of the Venture Challenge are:

Beephonix – a dynamic biomimetic microphone – Martijn Agterberg, Radboud University

D4BST – filling the diagnostic gap with DNA-based cell counting – Pieter A. van der Velden, Leiden University Medical Center

Genetic engineering technologies for high efficiency production of protein therapeutics – Christian Südfeld, Wageningen University & Research

NatInLab – development of medicines against viral respiratory tract infections by stimulating cell self-immune resistance through the regulation of proteolytic pathways – Ewelina Weglarz-Tomczak

PrecorDx – reducing heart failure hospitalizations with wearable diagnostics – Bart Steensma, University Medical Center Utrecht

The process

These teams of academic entrepreneurs in the life sciences will be guided by business experts, seasoned entrepreneurs during 3-day bootcamp sessions. At the end of the Venture Challenge program, the participants will pitch their plans to a jury of experienced entrepreneurs and investors, who will also select the winner of a cheque for 25,000 euros. On 9 September, during the Dutch Biotech Event, the winner of the past spring round will be announced.

For more information about The Venture Challenge you can visit: